﻿<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.google.com/schemas/sitemap/0.84" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.google.com/schemas/sitemap/0.84 http://www.google.com/schemas/sitemap/0.84/sitemap.xsd">
  <url>
    <loc>http://epogen.legalview.com/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/jury-verdicts/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/jury-verdicts/sitemap.xml</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/fda-alerts/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/fda-alerts/fda-advises-consumers-to-avoid-toothpaste-from-china-containing-harmfu/363045/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/fda-alerts/fda-commissioner-announces-new-food-protection-position/347043/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/fda-alerts/fda-announces-audio-broadcasts-on-emerging-drug-safety-information/340988/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/fda-alerts/fda-drug-safety-podcasts-podcasts-by-topic/447594/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/fda-alerts/information-on-erythropoiesis-stimulating-agents-esa-marketed-as-procr/447595/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/fda-alerts/information-for-healthcare-professionals-erythropoiesis-stimulating-ag/447597/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/fda-alerts/public-health-advisory-recombinant-human-erythropoietins-marketed-as-p/447596/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/fda-alerts/whats-new-from-the-office-of-oncology-drug-products/447598/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/fda-alerts/erythropoiesis-stimulating-agents-esas/447599/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/fda-alerts/epoetin-alfa-product-approval-information-licensing-action/516303/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/fda-alerts/epoetin-alfa-product-approval-information-licensing-action/516304/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/news-articles/sitemap.xml</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/msn/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/msn/sitemap.xml</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/patents/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/patents/production-of-erthropoietin/322190/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/thank-you.aspx</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/disclaimer.aspx</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/ContactUs.aspx</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/local/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://epogen.legalview.com/local/sitemap.xml</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
</urlset>
